These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 33376528)

  • 21. High expression of
    Lin B; Zhang T; Ye X; Yang H
    Oncol Lett; 2020 Sep; 20(3):2840-2854. PubMed ID: 32782602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of the Six-RNA-Binding Protein Signature for Prognosis Prediction in Bladder Cancer.
    Wu Y; Liu Y; He A; Guan B; He S; Zhang C; Kang Z; Gong Y; Li X; Zhou L
    Front Genet; 2020; 11():992. PubMed ID: 32983230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of SHMT2 Predicts a Poor Prognosis and Promotes Tumor Cell Growth in Bladder Cancer.
    Zhang P; Yang Q
    Front Genet; 2021; 12():682856. PubMed ID: 34149818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolyl 4-hydroxylase subunit beta (P4HB) could serve as a prognostic and radiosensitivity biomarker for prostate cancer patients.
    Feng D; Li L; Li D; Wu R; Zhu W; Wang J; Ye L; Han P
    Eur J Med Res; 2023 Jul; 28(1):245. PubMed ID: 37480146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RNA-Sequencing Data Reveal a Prognostic Four-lncRNA-Based Risk Score for Bladder Urothelial Carcinoma: An in Silico Update.
    He RQ; Huang ZG; Li TY; Wei YP; Chen G; Lin XG; Wang QY
    Cell Physiol Biochem; 2018; 50(4):1474-1495. PubMed ID: 30359990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Multiomics Profiling Based on Online Database Revealed Prognostic Biomarkers of BLCA.
    Li H; Chen S; Mi H
    Biomed Res Int; 2022; 2022():2449449. PubMed ID: 35669725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of SNCA and its methylation in bladder cancer.
    Wu Z; Xia C; Zhang C; Yang D; Ma K
    BMC Cancer; 2022 Mar; 22(1):330. PubMed ID: 35346107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A potential prognostic lncRNA signature for predicting survival in patients with bladder urothelial carcinoma.
    Bao Z; Zhang W; Dong D
    Oncotarget; 2017 Feb; 8(6):10485-10497. PubMed ID: 28060759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognosis and immune infiltration analysis of endoplasmic reticulum stress-related genes in bladder urothelial carcinoma.
    Wang Y; Zhu H; Wang X
    Front Genet; 2022; 13():965100. PubMed ID: 36186448
    [No Abstract]   [Full Text] [Related]  

  • 30. Establishment of prognostic model of bladder cancer based on apoptosis-related genes, in which P4HB promotes BLCA progression.
    Zou Z; Li Z; Sun W; Gao W; Liu B; Liu J; Guo Y
    BMC Urol; 2023 Oct; 23(1):167. PubMed ID: 37845668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of FADS1 Through Common Gene Expression Profiles for Predicting Survival in Patients with Bladder Cancer.
    Jiao F; Sun H; Yang Q; Sun H; Wang Z; Liu M; Chen J
    Cancer Manag Res; 2020; 12():8325-8339. PubMed ID: 32982427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Novel CpG Methylation Risk Indicator for Predicting Prognosis in Bladder Cancer.
    Guo Y; Yin J; Dai Y; Guan Y; Chen P; Chen Y; Huang C; Lu YJ; Zhang L; Song D
    Front Cell Dev Biol; 2021; 9():642650. PubMed ID: 34540821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive Analysis of the Expression, Prognosis, and Biological Significance of PLOD Family in Bladder Cancer.
    Chen R; Jiang M; Hu B; Fu B; Sun T
    Int J Gen Med; 2023; 16():707-722. PubMed ID: 36872941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of prolyl 4-hydroxylase beta-polypeptide in non-small cell lung cancer treated with Chinese medicines.
    Wang SM; Lin LZ; Zhou DH; Zhou JX; Xiong SQ
    Chin J Integr Med; 2015 Sep; 21(9):689-96. PubMed ID: 24382781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a Prognostic Signature Associated With the Homeobox Gene Family for Bladder Cancer.
    Dong B; Liang J; Li D; Song W; Song J; Zhu M; Zhao S; Ma Y; Yang T
    Front Mol Biosci; 2021; 8():688298. PubMed ID: 34368227
    [No Abstract]   [Full Text] [Related]  

  • 36. Expression and Prognostic Values of the Roof Plate-Specific Spondin Family in Bladder Cancer.
    Gao L; Meng J; Zhang M; Fan S; Gao S; Wang X; Liang C
    DNA Cell Biol; 2020 Jun; 39(6):1072-1089. PubMed ID: 32352838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HSPB8 is a Potential Prognostic Biomarker that Correlates With Immune Cell Infiltration in Bladder Cancer.
    Tan Z; Fu S; Huang Y; Duan X; Zuo Y; Zhu X; Wang H; Wang J
    Front Genet; 2022; 13():804858. PubMed ID: 35330734
    [No Abstract]   [Full Text] [Related]  

  • 38. EPHA3 Could Be a Novel Prognosis Biomarker and Correlates with Immune Infiltrates in Bladder Cancer.
    Liu J; Zhou Z; Jiang Y; Lin Y; Yang Y; Tian C; Liu J; Lin H; Huang B
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An RNA-sequencing-based transcriptome for a significantly prognostic novel driver signature identification in bladder urothelial carcinoma.
    Liu D; Zhou B; Liu R
    PeerJ; 2020; 8():e9422. PubMed ID: 32742772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel signature constructed by ferroptosis-associated genes (FAGs) for the prediction of prognosis in bladder urothelial carcinoma (BLCA) and associated with immune infiltration.
    Luan JC; Zeng TY; Zhang QJ; Xia DR; Cong R; Yao LY; Song LB; Zhou X; Zhou X; Chen X; Xia JD; Song NH
    Cancer Cell Int; 2021 Aug; 21(1):414. PubMed ID: 34362387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.